Massachusetts General Hospital Collaboration

October 20, 2020

In the fight against COVID-19, ImmunoScape is joining forces with Dr. Patrick Reeves, Team Leader at the Massachusetts General Hospital Vaccine & Immunotherapy Center, using its signature assay, TargetScape, to perform high-dimensional immune profiling of COVID-19 induced changes across immune populations and phenotypes with a focus on antigen-specific T cells. The study will investigate the immune response during distinct phases of COVID-19 and assess the correlation between disease severity and cellular immune response profiles.